Page last updated: 2024-12-05

cadmium acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cadmium acetate: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10986
SCHEMBL ID20830
MeSH IDM0090638

Synonyms (35)

Synonym
bis(acetoxy)cadmium
nsc-75795
acetic acid, cadmium salt
cadmium diacetate
c.i. 77185
ai3-02414
ci 77185
hsdb 280
einecs 208-853-2
ai3-01414
cadmium di(acetate)
cadmium(ii) acetate
nsc 75795
ccris 7783
cadmium ethanoate
acetic acid, cadmium salt dihydrate
543-90-8
cadmium acetate
unii-sa10ix931v
unii-95kc50z1l0
95kc50z1l0 ,
acetic acid, cadmium salt (2:1)
FT-0623363
AKOS015915937
acetic acid cadmium salt (2:1)
cadmium acetate [hsdb]
cadmium acetate [mi]
SCHEMBL20830
LHQLJMJLROMYRN-UHFFFAOYSA-L
cadmium (ii) acetate
DTXSID1020225
cadmium acetate anhydrous 98%
Q419714
cadmiumacetate
cadmium(2+);diacetate

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"In this study, cadmium (Cd) relative bioavailability in contaminated (n = 5) and spiked (n = 2) soils was assessed using an in vivo mouse model following administration of feed containing soil or Cd acetate (reference material) over a 15 day exposure period."( Determination of cadmium relative bioavailability in contaminated soils and its prediction using in vitro methodologies.
Gancarz, D; Juhasz, AL; Naidu, R; Rofe, A; Smith, E; Todor, D; Weber, J, 2010
)
0.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (80)

TimeframeStudies, This Drug (%)All Drugs %
pre-199020 (25.00)18.7374
1990's16 (20.00)18.2507
2000's18 (22.50)29.6817
2010's23 (28.75)24.3611
2020's3 (3.75)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.39 (24.57)
Research Supply Index4.48 (2.92)
Research Growth Index4.58 (4.65)
Search Engine Demand Index70.08 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.15%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other86 (98.85%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]